AstraZeneca PLC Share Price Deutsche Boerse AG
Stocks
ZEG
GB0009895292
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 148.32 EUR | -0.45% |
|
+0.07% | -5.34% |
| 07:07pm | AstraZeneca says two treatments backed for EU approval | AN |
| 05:13pm | AstraZeneca's Trixeo Recommended for EU Approval to Treat Asthma | MT |
| Market Cap | 26TCr 23TCr 21TCr 20TCr 37TCr 25,36100Cr 38TCr 2,55900Cr 1LCr 12,37000Cr 98TCr 96TCr 42,91500Cr | P/E 2026 * |
21.1x | P/E 2027 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 28TCr 25TCr 23TCr 21TCr 40TCr 27,22000Cr 40TCr 2,74600Cr 1,07100Cr 13,27700Cr 1,05500Cr 1,03200Cr 46,06100Cr | EV / Sales 2026 * |
4.45x | EV / Sales 2027 * | 4.1x |
| Free-Float |
96.63% | Yield 2026 * |
1.98% | Yield 2027 * | 2.09% |
Last Transcript: AstraZeneca PLC
| 1 day | -0.45% | ||
| 1 week | +0.07% | ||
| Current month | -8.38% | ||
| 1 month | -7.30% | ||
| 3 months | -6.61% | ||
| 6 months | -6.58% | ||
| Current year | -5.34% |
| 1 week | 144.85 |  | 151.2 |
| 1 month | 143.7 | | 170.35 |
| Current year | 143.7 | | 180.45 |
| 1 year | 124.1 | | 180.45 |
| 3 years | 112.45 | | 180.45 |
| 5 years | 94.11 | | 180.45 |
| 10 years | 47.74 | | 180.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 01/10/2012 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 01/08/2021 |
Jeffrey Pott
CMP | Compliance Officer | - | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 06/04/1999 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 01/10/2012 |
Philip Broadley
BRD | Director/Board Member | 65 | 27/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.45% | +0.07% | - | - | 26TCr | |
| +1.26% | +1.76% | +48.97% | +161.22% | 1,05700Cr | |
| +1.52% | +3.87% | +55.01% | +53.64% | 62TCr | |
| +1.00% | +2.01% | +36.04% | +81.32% | 45TCr | |
| +1.60% | +6.25% | +33.95% | +29.84% | 34TCr | |
| -0.60% | +1.52% | +35.68% | +39.76% | 30TCr | |
| +0.09% | -2.82% | -28.29% | -41.71% | 22TCr | |
| +1.44% | +2.86% | +22.11% | +60.04% | 20TCr | |
| -0.42% | -3.08% | +14.96% | +67.58% | 16TCr | |
| +0.18% | -1.70% | -2.86% | -34.35% | 14TCr | |
| Average | +0.55% | +0.66% | +23.95% | +46.37% | 38.83TCr | |
| Weighted average by Cap. | +0.85% | +1.56% | +35.77% | +77.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.32TCr 5.56TCr 5.16TCr 4.75TCr 8.91TCr 6,12100Cr 9.07TCr 62TCr 24TCr 2,98600Cr 24TCr 23TCr 10,35800Cr | 6.68TCr 5.87TCr 5.46TCr 5.02TCr 9.41TCr 6,46700Cr 9.58TCr 65TCr 25TCr 3,15400Cr 25TCr 25TCr 10,94300Cr |
| Net income | 1.24TCr 1.09TCr 1.02TCr 934.13Cr 1.75TCr 1,20400Cr 1.78TCr 12TCr 4.74TCr 59TCr 4.67TCr 4.57TCr 2,03700Cr | 1.39TCr 1.22TCr 1.14TCr 1.05TCr 1.96TCr 1,34900Cr 2TCr 14TCr 5.31TCr 66TCr 5.23TCr 5.12TCr 2,28200Cr |
| Net Debt | 1.92TCr 1.69TCr 1.57TCr 1.44TCr 2.71TCr 1,85900Cr 2.75TCr 19TCr 7.32TCr 91TCr 7.21TCr 7.05TCr 3,14600Cr | 1.19TCr 1.05TCr 972.51Cr 894.44Cr 1.68TCr 1,15300Cr 1.71TCr 12TCr 4.54TCr 56TCr 4.47TCr 4.37TCr 1,95100Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | €149.85 | +0.57% | 466 |
| 23/26/23 | €149.00 | +0.20% | 2,140 |
| 22/26/22 | €148.70 | +1.71% | 1,168 |
| 21/26/21 | €146.20 | +0.93% | 18 |
| 20/26/20 | €144.85 | -3.27% | 263 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
- ZEG Stock
Select your edition
All financial news and data tailored to specific country editions
